According to a NASA Media Advisory issued on July 23, 2026, NASA astronaut Chris Williams and Roscosmos cosmonauts Sergey Kud-Sverchkov and Sergei Mikaev will depart the International Space Station on Sunday, July 26, ending an eight-month mission that yielded advances in space-manufactured cancer nanomaterials and semiconductor crystal growth. Soyuz MS-28 is scheduled to undock from the station’s Rassvet module at 3:02 a.m. ET and land on the Kazakh steppe southeast of Dzhezkazgan at 6:26 a.m. ET.
Williams Advances Oncology Research in Microgravity
According to his NASA astronaut biography, Williams arrived on the station with a research portfolio anchored in oncology and materials science, reflecting his background as a former medical physicist and assistant professor at Harvard Medical School. The centerpiece of that work involved Janus base nanomaterials, or JBNs, which are synthetic molecules engineered from DNA-inspired building blocks designed to self-assemble into hollow nanotubes that carry therapeutic payloads directly to solid tumors, as confirmed by an ISS National Lab announcement from April 9, 2026. On Earth, gravity-driven convection and sedimentation disrupt this self-assembly process, yielding inconsistent dimensions that reduce drug-loading capacity. In microgravity, those convective forces are absent. Earlier research sponsored by Eascra Biotech and UConn demonstrated that JBNs manufactured in orbit form more uniform and durable structures, advancing Williams’s work toward application-stage candidates targeting triple-negative breast cancer, high-grade ovarian cancer, and select bone cancers.
Spacewalks and Countermeasure Testing on Expedition 74
According to Expedition 74 records, Williams completed two spacewalks alongside NASA astronaut Jessica Meir totaling 13 hours and 7 minutes, including a June 2026 excursion that replaced a broken wrist joint on Canadarm2. Meanwhile, Kud-Sverchkov spent the final days of the mission packing cargo and testing a lower-body negative pressure suit, a device creating a partial vacuum around an astronaut’s lower body to counteract the cephalad fluid shift that occurs in microgravity and accelerates cardiovascular readaptation after landing. Mikaev participated in the same countermeasure program.
Meir Takes Command as Expedition 75 Begins
According to the Expedition 75 mission page, Meir is scheduled to assume command of the orbital complex on Saturday, July 25, at 9:40 a.m. ET in a formal change-of-command ceremony. Meir, a Norwegian-American marine biologist who launched as Crew-12 commander on February 13, 2026, will lead a seven-member crew that includes three newcomers who arrived aboard Soyuz MS-29 on July 14. That crew will continue the research agenda through spring 2027.
Did you know? A light-speed signal takes 3 to 22 minutes to travel between Earth and Mars depending on orbital positions, making real-time physician guidance impossible during deep-space exploration, according to NASA mission planning documents.
Expedition 75 Tests Autonomous Medicine and Bioprinting
According to NASA’s Menon mission announcement, NASA flight engineer Anil Menon will serve as primary science officer for Expedition 75 medical research, testing AI-guided, augmented-reality ultrasound diagnostics designed to operate without real-time Earth support. Menon will also participate in studies examining how microgravity alters blood circulation and vein structure while the crew continues 3D bioprinting of vascular constructs in microgravity, where the absence of gravity prevents soft tissues from collapsing before they cure.
Frequently Asked Questions
Why does microgravity improve cancer drug research?
According to the ISS National Lab, gravity-driven convection and sedimentation disrupt the self-assembly of synthetic nanomaterials like JBNs on Earth. Microgravity suppresses these forces, allowing nanotubes to form more uniform and durable structures with improved drug-loading capacity.
What does the ISS 2030 deorbit mean for research?
With the ISS scheduled to deorbit at the end of 2030, current research programs like cancer nanomaterial production and semiconductor crystal growth face a hard deadline to transition to commercial successor stations before the orbital laboratory goes out of service.
How will AI and augmented reality change space medicine?
According to NASA, AI interpretation algorithms and augmented reality overlays will guide astronauts through diagnostic ultrasound procedures without real-time Earth support, overcoming communication delays inherent to missions to the Moon and Mars.
Who is Jessica Meir?
According to mission overviews, Meir is a Norwegian-American marine biologist, veteran of Expeditions 61 and 62, and Crew-12 commander who performed the first all-female spacewalk in 2019 and now commands both the Dragon spacecraft and the ISS.
Explore More: Want to stay updated on orbital research and upcoming crew rotations? Subscribe to our newsletter or browse our latest space exploration coverage.